TEST:

LiquidLung™

The LiquidLung™ liquid biopsy program, designed for targeted screening, confirmatory diagnosis and histologic typing and subtyping of lung cancer, is positioned to rule more patients with an elevated risk of developing lung cancer into evidence-based imaging pathways earlier, eliminate unnecessary invasive biopsies for patients with suspicious pulmonary nodules discovered incidentally and/or through routine screening, and to accelerate the time to the most precise histology-specific treatment.